James M. Balkovec

4.4k citations

47 papers · 2.9k indexed · 1 hit paper · h-index 27

Co-authors: Barry M. Trost George K. Abruzzo James F. Dropinski Ken Bartizal John L. Belletire Patrick G. McDougal Sándor Varga Stephen A. Godleski
Topics: Antifungal resistance and susceptibility (11 papers)Hormonal Regulation and Hypertension (9 papers)Pneumocystis jirovecii pneumonia detection and treatment (8 papers)
Cited by: Infectious Diseases Molecular Medicine Pharmacology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States

In The Last Decade

James M. Balkovec

46 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcohols

1986 536 citations Barry M. Trost, John L. Belletire et al. The Journal of Organic Chemistry profile →

Peers

Countries citing papers authored by James M. Balkovec

Since Specialization

Citations

This map shows the geographic impact of James M. Balkovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Balkovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Balkovec more than expected).

Fields of papers citing papers by James M. Balkovec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Balkovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Balkovec. The network helps show where James M. Balkovec may publish in the future.

Co-authorship network of co-authors of James M. Balkovec

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Balkovec. A scholar is included among the top collaborators of James M. Balkovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Balkovec. James M. Balkovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CTC-177, a novel drug–Fc conjugate, shows promise as an immunoprophylactic agent against multidrug-resistant Gram-negative bacterial infections 2024 ·JAC-Antimicrobial Resistance ·(unknown),Annie Lee,(unknown),(unknown),Mingming Wang,Padmaja Paderu,(unknown),Grayson Hough,Qiping Zhao,James M. Balkovec,David S. Perlin,Yanan Zhao	0
2	Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections 2021 ·Antimicrobial Agents and Chemotherapy ·(unknown),(unknown),Allen Borchardt,(unknown),Jason N. Cole,(unknown),(unknown),Grayson Hough,Wanlong Jiang,(unknown),(unknown),Qiping Zhao,James M. Balkovec,Yanan Zhao,David S. Perlin	4
3	Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study 2013 ·Natural Product Reports ·James M. Balkovec,David L. Hughes,Prakash Masurekar,Carole A. Sable,Robert E. Schwartz,Sheo B. Singh	122
4	Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome 2011 ·Bioorganic & Medicinal Chemistry Letters ·Milana Maletic,(unknown),Michael J. Szymonifka,Steven S. Mundt,Hratch J. Zokian,Kashmira Shah,Jasminka Dragovic,Kathy Lyons,Rolf Thieringer,(unknown),James M. Balkovec,Sherman T. Waddell	12
5	Synthesis of oxaspiropiperidines as a strategy for lowering logD 2011 ·Tetrahedron Letters ·(unknown),Kevin D. Dykstra,Dorothy Levorse,Andreas Verras,James M. Balkovec,Ravi P. Nargund,Robert J. DeVita	2
6	Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Steven H. Olson,Donald W. Graham,Gool F. Patel,Anne Hermanowski‐Vosatka,Steven S. Mundt,Kashmira Shah,Marty S. Springer,Rolf Thieringer,Samuel D. Wright,Jianying Xiao,Hratch J. Zokian,Jasminka Dragovic,James M. Balkovec	38
7	Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach 2006 ·Xenobiotica ·(unknown),Steven H. Olson,James M. Balkovec,Yunping Zhu,Inmaculada Royo,Jocelyn Yabut,Raymond Evers,(unknown),Wei Tang,Dylan P. Hartley,Ralph T. Mosley	51
8	Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome 2005 ·Bioorganic & Medicinal Chemistry Letters ·Xin Gu,Jasminka Dragovic,Gloria C. Koo,Sam L. Koprak,(unknown),Steven S. Mundt,Kashmira Shah,Marty S. Springer,(unknown),Rolf Thieringer,Anne Hermanowski‐Vosatka,Hratch J. Zokian,James M. Balkovec,Sherman T. Waddell	40
9	A novel non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of metabolic syndrome in murine disease models 2004 ·Rolf Thieringer,James M. Balkovec,(unknown),(unknown),(unknown),(unknown),(unknown),Steven S. Mundt,(unknown),(unknown),Steven H. Olson,(unknown),(unknown),J Schaeffer,S. Wright,(unknown),(unknown)	6
10	Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase 2001 ·Journal of Biological Chemistry ·Jeffrey H. Toney,Gail G. Hammond,Paula M.D. Fitzgerald,Nandini Sharma,James M. Balkovec,(unknown),Steven H. Olson,Milton L. Hammond,Mark L. Greenlee,Ying‐Duo Gao	171
11	Inhibition of IMP-1 metallo-Î²-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives 1999 ·FEMS Microbiology Letters ·Gail G. Hammond,Joann Huber,Mark L. Greenlee,(unknown),Katherine Young,Lynn L. Silver,James M. Balkovec,KellyAnn D. Pryor,Joseph K. Wu,Barbara Leiting,David L. Pompliano,Jeffrey H. Toney	42
12	Synthesis and SAR of thioester and thiol inhibitors of IMP-1 Metallo-β-Lactamase 1999 ·Bioorganic & Medicinal Chemistry Letters ·Mark L. Greenlee,(unknown),James M. Balkovec,Milton L. Hammond,Gail G. Hammond,David L. Pompliano,(unknown)	49
13	Elongation Factor 2 as a Novel Target for Selective Inhibition of Fungal Protein Synthesis 1998 ·Journal of Biological Chemistry ·Michael Justice,Ming‐Jo Hsu,(unknown),(unknown),James M. Balkovec,Dennis M. Schmatz,Jennifer Nielsen	148
14	Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),James M. Balkovec,Charles M. Blazey,Ming‐Jo Hsu,Jennifer Nielsen,Dennis M. Schmatz	24
15	In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) 1997 ·Antimicrobial Agents and Chemotherapy ·(unknown),Christopher Gill,George K. Abruzzo,Amy Flattery,L. Kong,Patricia M. Scott,Jeffrey G. Smith,(unknown),Alice Bouffard,James F. Dropinski,James M. Balkovec	262
16	Determination of the Absolute Stereochemistry of (−)-Galbonolide A 1997 ·The Journal of Organic Chemistry ·(unknown),Charles M. Blazey,(unknown),James M. Balkovec	12
17	Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives 1994 ·Journal of Medicinal Chemistry ·F. Aileen Bouffard,Robert A. Zambias,James F. Dropinski,James M. Balkovec,Milton L. Hammond,George K. Abruzzo,Kenneth F. Bartizal,J A Marrinan,Myra B. Kurtz	94
18	Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP) 1992 ·Journal of Medicinal Chemistry ·James M. Balkovec,Regina M. Black,Milton L. Hammond,James V. Heck,Robert A. Zambias,George K. Abruzzo,Ken Bartizal,H Kropp,(unknown)	55
19	On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcoholsbreakdown → 1986 ·The Journal of Organic Chemistry ·Barry M. Trost,John L. Belletire,Stephen A. Godleski,Patrick G. McDougal,James M. Balkovec,John J. Baldwin,Marcia E. Christy,G. S. PONTICELLO,Sándor Varga,James P. Springer	536
20	A total synthesis of plumericin, allamcin, and allamandin. Part 1. Basic strategy 1986 ·Journal of the American Chemical Society ·Barry M. Trost,Michael K. Mao,James M. Balkovec,Peter Bühlmayer	37

About James M. Balkovec

James M. Balkovec is a scholar working on Toxicology, Infectious Diseases and Molecular Medicine, having authored 47 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (11 papers), Hormonal Regulation and Hypertension (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Molecular Medicine (230 citations) and Pharmacology (592 citations). James M. Balkovec has collaborated with scholars based in United States. Frequent co-authors include Barry M. Trost, George K. Abruzzo, James F. Dropinski, Ken Bartizal, John L. Belletire, Patrick G. McDougal, Sándor Varga, Stephen A. Godleski, G. S. PONTICELLO and James P. Springer. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact